Page last updated: 2024-08-25

honokiol and Cancer of Ovary

honokiol has been researched along with Cancer of Ovary in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luo, H; Wu, Q; Yi, T; Zhang, M1
Cha, EY; Ko, YB; Lee, JS; Lee, MS; Park, JB; Sul, JY1
Chen, L; Gou, M; Guo, G; Luo, F; Men, K; Peng, X; Qian, Z; Wei, Y; Zeng, S; Zhao, X; Zheng, L; Zheng, X1
Chen, L; Fu, S; Gou, M; Kan, B; Luo, F; Men, K; Qian, Z; Wei, Y; Zhang, J; Zhao, X; Zhao, Y; Zheng, X1
Chen, LJ; Fu, AF; Lin, HG; Luo, H; Qi, XR; Wei, YQ; Yang, F; Yang, HS; Zhao, X; Zhong, Q1
Chen, L; Huang, C; Li, Z; Liu, Y; Pan, X; Wei, Y; Yin, R; Zhao, X1

Other Studies

6 other study(ies) available for honokiol and Cancer of Ovary

ArticleYear
Self-Assembled Honokiol-Loaded Microbubbles in the Treatment of Ovarian Cancer by Ultrasound Irradiation.
    Journal of biomedical nanotechnology, 2018, Oct-01, Volume: 14, Issue:10

    Topics: Animals; Biphenyl Compounds; Female; Humans; Lignans; Mice; Mice, Nude; Microbubbles; Ovarian Neoplasms; Particle Size; Polyesters; Polyethylene Glycols; Ultrasonic Waves

2018
Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway.
    International journal of molecular medicine, 2019, Volume: 43, Issue:5

    Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Enzyme Activation; Female; Humans; Lignans; Mice; Models, Biological; Neoplasm Invasiveness; NIH 3T3 Cells; Ovarian Neoplasms; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Stem Cell Assay

2019
Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    International journal of pharmaceutics, 2009, Jun-22, Volume: 375, Issue:1-2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Line; Cell Line, Tumor; Drug Carriers; Drugs, Chinese Herbal; Erythrocytes; Female; Hemolysis; Humans; Lignans; Nanoparticles; Ovarian Neoplasms; Particle Size; Polyesters; Polyethylene Glycols; Rabbits; Solvents

2009
Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro.
    International journal of pharmaceutics, 2010, Feb-15, Volume: 386, Issue:1-2

    Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Chromatography, Gel; Dose-Response Relationship, Drug; Drug Carriers; Female; Hemolysis; Humans; Kinetics; Lignans; Magnetic Resonance Spectroscopy; Molecular Structure; Molecular Weight; Nanoparticles; Nanotechnology; Ovarian Neoplasms; Particle Size; Polyesters; Polyethylene Glycols; Solubility; Solvents; Surface Properties; Technology, Pharmaceutical

2010
Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer.
    Journal of cancer research and clinical oncology, 2008, Volume: 134, Issue:9

    Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Lignans; Liposomes; Mice; Mice, Nude; Ovarian Neoplasms

2008
Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
    European journal of obstetrics, gynecology, and reproductive biology, 2008, Volume: 140, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Lignans; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms

2008